Development of cellulose-DNA immunoadsorbent.
The aim of this study was to prepare a DNA immunoadsorbent for the specific, extracorporeal removal of anti-DNA antibodies from the blood of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Two kinds of cellulose beads were applied as a carrier. Calf thymus DNA was covalently coupled to the carrier using the epichlorohydrin method. Efforts were focused on optimization of conditions for activation and coupling, trying to couple as much DNA as possible to a certain amount of carrier. It was found that the activation level increased with the increase of NaOH concentration and the amount of epichlorohydrin used. The mole of epichlorohydrin must be in excess of that of NaOH because excess NaOH could react further with the epoxy groups in the beads resulting in a decrease of activation level. High activation level could be obtained in a medium of 3.0 M NaOH. The DNA coupling was found to be mainly temperature and pH dependent. Using 0.1 M Tris-HCl buffer, pH 8 at a temperature of 50-90 degrees C, more than 3 mg of DNA could be coupled to 1 ml of wet beads. Prolonging the coupling reaction under 50 degrees C to 72 h resulted in the same coupling capacity as that obtained under 90 degrees C. To evaluate the adsorption ability for anti-DNA of this immunoadsorbent, batch and circulation tests were applied using SLE patient plasma. The immunoadsorbents showed excellent adsorption capacity, especially the cellulose with smaller size (200-300 microm). The incubation of 20 ml of patient's plasma with 1 ml of adsorbent resulted in an 80% decline in the anti-DNA antibody level. In the circulation tests, 30 ml of plasma was circulated through a column containing 3 ml of adsorbent. The maximum decline in anti-DNA level, 80%, was obtained after 60 min. Such high adsorption capacity and high adsorption rate suggest this immunoadsorbent may be used for treatment. For comparison, 1,4-butanediol diglycidyl ether activation method and other DNA sources were tested with the same protocol.
Kong
Deling
D
Research and Development Center of Bioengineering GmbH, Teterow, Germany.
Schuett
Wolfgang
W
Dai
Jun
J
Kunkel
Siegfred
S
Holtz
Manfred
M
Yamada
Ryo
R
Yu
Yaoting
Y
Klinkmann
Horst
H
D000327:Adsorption; D001172:Arthritis, Rheumatoid / Q000628:therapy*; D002482:Cellulose; D004247:DNA / Q000276:immunology; D006801:Humans; D007164:Immunosorbents; D008180:Lupus Erythematosus, Systemic / Q000628:therapy*; D010316:Particle Size; D012685:Sepharose / Q000627:therapeutic use
D007164:Immunosorbents; D002482:Cellulose; D004247:DNA; D012685:Sepharose